Campoy Carlos
SEC CIK 1761518 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | CFO | 38.2K | — | $9,069 | 4 | 2022-02-02 | 2023-03-16 |
Most active insiders at CTMX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McCarthy Sean A. | CEO, Dir | — | $1.23M |
| 2 | BELVIN MARCIA | SVP, CSO | — | $202.2K |
| 3 | Chu Yu-Waye | Chief Medical Off | — | $136.6K |
| 4 | Ogden Christopher | CFO | — | $129.0K |
| 5 | Lester Rachael | Chief Business Off | — | — |
| 6 | Carvajal Alejandra | CLO | — | — |
Campoy Carlos made no open-market trades at CTMX in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-20 | 2023-03-16 | CTMX | CytomX Therapeutics, Inc. | Campoy Carlos | CFO | S - Sale | $1.98 | -1,748 | 38.2K | -4% | -$3,461 | |
| 2022-07-21 | 2022-07-19 | CTMX | CytomX Therapeutics, Inc. | Campoy Carlos | CFO | A - Grant | $0.00 | +15.0K | 43.9K | +52% | $0 | |
| 2022-07-21 | 2022-07-20 | CTMX | CytomX Therapeutics, Inc. | Campoy Carlos | CFO | S - Sale | $1.42 | -3,949 | 40.0K | -9% | -$5,608 | |
| D | 2022-02-04 | 2022-02-02 | CTMX | CytomX Therapeutics, Inc. | Campoy Carlos | CFO | A - Grant | $0.00 | +22.5K | 28.9K | +350% | $0 |
Purchase Sale Sale after option exercise All abbreviations